Frick KK, Asplin JR, Favus MJ, Culbertson C, Krieger NS, Bushinsky DA. Increased biological response to 1,25(OH)2D3 in genetic hypercalciuric stone-forming rats. Am J Physiol Renal Physiol 304: F718-F726, 2013. First published January 23, 2013 doi:10.1152/ajprenal.00645.2012.-Genetic hypercalciuric stone-forming (GHS) rats, bred to maximize urine (U) calcium (Ca) excretion, have increased intestinal Ca absorption and bone Ca resorption and reduced renal Ca reabsorption, leading to increased UCa compared with the Sprague-Dawley (SD) rats. GHS rats have increased vitamin D receptors (VDR) at each of these sites, with normal levels of 1,25(OH)2D3 (1,25D), indicating that their VDR is undersaturated with 1,25D. We tested the hypothesis that 1,25D would induce a greater increase in UCa in GHS rats by feeding both strains ample Ca and injecting 1,25D (25 ng · 100 g body wt Ϫ1 · day Ϫ1 ) or vehicle for 16 days. With 1,25D, UCa in SD increased from 1.7 Ϯ 0.3 mg/day to 24.4 Ϯ 1.2 (⌬ ϭ 22.4 Ϯ 1.5) and increased more in GHS from 10.5 Ϯ 0.7 to 41.9 Ϯ 0.7 (⌬ ϭ 29.8 Ϯ 1.8; P ϭ 0.003). To determine the mechanism of the greater increase in UCa in GHS rats, we measured kidney RNA expression of components of renal Ca transport. Expression of transient receptor potential vanilloid (TRPV)5 and calbindin D28K were increased similarly in SD ϩ 1,25D and GHS ϩ 1,25D. The Na ϩ /Ca 2ϩ exchanger (NCX1) was increased in GHS ϩ 1,25D. Klotho was decreased in SD ϩ 1,25D and GHS ϩ 1,25D. TRPV6 was increased in SD ϩ 1,25D and increased further in GHS ϩ 1,25D. Claudin 14, 16, and 19, Na/K/2Cl transporter (NKCC2), and secretory K channel (ROMK) did not differ between SD ϩ 1,25D and GHS ϩ 1,25D. Increased UCa with 1,25D in GHS exceeded that of SD, indicating that the increased VDR in GHS induces a greater biological response. This increase in UCa, which must come from the intestine and/or bone, must exceed any effect of 1,25D on TRPV6 or NCX1-mediated renal Ca reabsorption. vitamin D; calcium; kidney stones; reabsorption HYPERCALCIURIA IS THE MOST common metabolic abnormality in patients with nephrolithiasis(19). Hypercalciuria leads to increased urine (U) supersaturation (SS) with respect to the solid phases of calcium hydrogen phosphate (CaHPO 4 , brushite) and calcium oxalate (CaOx), enhancing the probability of nucleation and growth of crystals into clinically significant stones (19). In humans, idiopathic hypercalciuria (IH) is characterized by increased intestinal calcium (Ca) absorption and/or decreased renal tubule Ca reabsorption resulting in hypercalciuria with normal serum (S) Ca, normal or elevated S1,25(OH) 2 D 3 (1,25D), normal S parathyroid hormone (PTH), normal or low S phosphate (P), and low bone mass (19, 70, 85) . The familial pattern of IH is consistent with a polygenic mode of inheritance (70, 71, 85) .
vitamin D; calcium; kidney stones; reabsorption HYPERCALCIURIA IS THE MOST common metabolic abnormality in patients with nephrolithiasis (19) . Hypercalciuria leads to increased urine (U) supersaturation (SS) with respect to the solid phases of calcium hydrogen phosphate (CaHPO 4 , brushite) and calcium oxalate (CaOx), enhancing the probability of nucleation and growth of crystals into clinically significant stones (19) . In humans, idiopathic hypercalciuria (IH) is characterized by increased intestinal calcium (Ca) absorption and/or decreased renal tubule Ca reabsorption resulting in hypercalciuria with normal serum (S) Ca, normal or elevated S1,25(OH) 2 D 3 (1,25D), normal S parathyroid hormone (PTH), normal or low S phosphate (P), and low bone mass (19, 70, 85) . The familial pattern of IH is consistent with a polygenic mode of inheritance (70, 71, 85) .
To study the pathophysiology of hypercalciuria and stone formation, we have established a strain of hypercalciuric rats by selectively inbreeding Sprague-Dawley (SD) rats for increased UCa excretion (3-5, 16 -18, 20 -25, 27-29, 31, 39, 45, 46, 51, 52, 54, 65, 80, 90, 97, 98) . After Ͼ80 generations of continuous selection and inbreeding, each rat consistently excretes approximately 8-to 10-fold higher levels of UCa than SD controls (3-5, 16 -18, 20 -25, 27-29, 31, 39, 45, 46, 51, 52, 54, 65, 80, 90, 97, 98) and also forms kidney stones (3, 22, 23, 27) . These hypercalciuric rats have been termed genetic hypercalciuric stone-forming (GHS) rats (3-5, 16 -18, 20 -25, 28, 29, 31, 39, 45, 46, 51, 52, 54, 65, 80, 90, 97, 98) .
The GHS rats exhibit many features of human idiopathic hypercalciuria including normal SCa (20, 33) , increased intestinal Ca absorption (65) and bone resorption (54) , decreased renal tubule Ca reabsorption (90) , and normal S1,25D levels (33) in addition to decreased bone mineral density (29, 39 ) and a polygenic mode of inheritance (45) . GHS rats have elevated levels of vitamin D receptor (VDR) protein in Ca-transporting organs including the kidney, intestine and bone (33, 37, 54) .
In humans the changes in intestine, kidney, and bone Ca transport in IH may be reproduced by the administration of 1,25D to normal volunteers leading to hypercalciuria (1, 68) . The increase in human UCa with 1,25D implies that the effect of 1,25D to increase intestinal Ca absorption (43) and bone Ca resorption (1, 68) overwhelms any 1,25D-mediated increase in renal tubular Ca reabsorption (12) . While elevated S1,25D levels may account for the phenotype in some patients (6, 14, 48, 83) , most patients with IH have normal S1,25D levels (99) . High VDR levels have been found in male IH stone formers in at least one study (34) , suggesting elevated VDR levels may play a role in hypercalciuria in human stone formers.
Since GHS rats have normal levels of S1,25D (33) , their elevated tissue levels of VDR (33, 37, 54) would be relatively undersaturated with 1,25D compared with SD rats. In spite of this relative undersaturation, the GHS rats have Ca transport abnormalities that are consistent with increased vitamin D signaling implying that additional 1,25D, leading to greater VDR saturation, would have a larger effect on Ca transport in the GHS than in SD rats. In this study we tested the hypothesis that the administration of an identical amount of 1,25D to GHS and SD rats would lead to a greater increment in hypercalciuria in the GHS rats. We measured not only UCa and U SS with respect to the solid phases CaOx and CaHPO 4 but also the renal abundance of RNA encoding components of renal tubular Ca reabsorption.
MATERIALS AND METHODS
Animals. The GHS rats were derived from SD rats (Charles River Laboratories, Kingston, NY) by successively inbreeding the most hypercalciuric progeny of each generation (17, 20, 22, 31, 39, 52, 54, 65, 90) . Eight-week-old male GHS rats from the 86th generation and 8-wk-old male SD rats (Charles River Laboratories) were used in this study.
Experimental conditions. On day 0, 16 SD and 16 GHS rats were placed in metabolic cages, fed 13 g/day normal Ca diet (1.2% Ca; Harlan-Teklad, Indianapolis, IN), and given deionized, distilled water ad libitum. Also starting on day 0, by random allocation, eight rats in each group were injected daily with 1,25D (25 ng/100 g body wt; American Regent, Shirley, NY) in saline and eight with only saline. This dose of 1,25D elicits a maximal physiologic response (97) . Starting on day 8, urine was collected for four 24-h periods. On days 9 and 11, urine was acidified with HCl and on days 10 and 12 urine was collected in thymol. Collections in thymol were used for pH and Cl and collections in HCl for all other measurements. On days 14, 15, and 16, rats were anesthetized and blood was collected by cardiac puncture. Rats were killed, and kidneys were quickly removed. Any animal that ate Ͻ10 g/day food or drank Ͻ15 ml/day water would have been excluded from further analysis; however, all rats met these prespecified criteria during the entire study. All procedures were approved by the University Committee for Animal Resources.
Urine and serum chemistries. Urine Ca, Mg, P, ammonia, and creatinine were measured spectrophotometrically using a Beckman CX5 Pro autoanalyzer (Beckman Instruments, Brea, CA). Change in UCa (⌬UCa) was estimated by pairing each SD ϩ 1,25D rat with a randomly assigned SD ϩ saline rat, and GHS ϩ 1,25D with a GHSϩsaline rat, and in each case calculating the difference. Urine K, Cl, and Na were measured by ion specific electrodes on the Beckman CX5. Urine pH was measured using a glass electrode and citrate, oxalate, and sulfate were measured by ion chromatography using a Dionex ICS 2000 system (Dionex, Sunnyvale, CA). Serum Ca and P were determined colorimetrically (BioVision, Milpitas, CA). Serum PTH was determined by EIA for intact-PTH (ALPCO, Salem, NH). For this assay, the standard curve was linear from 114 to 3,300 pg/ml. We have used these methods previously (3, 4, 29) .
Urine supersaturation. The CaOx and CaHPO 4 (CaP) ion activity product were calculated using the computer program EQUIL 2 (94) as we have done previously (16 -18, 21, 24, 25, 27, 28) . Ratios of 1 denote a sample at equilibrium, Ͼ1 denotes SS, and Ͻ1 denotes undersaturation. We have found excellent correspondence between calculated and experimentally measured saturation in urine and blood and in bone culture medium (3, 4, 29) .
RNA harvest and purification. Kidneys were bisected and placed in 2 ml RNAlater (Ambion, Grand Island, NY) at 4°C overnight and then transferred to Ϫ70°C until purification. Each kidney was homogenized in 6 ml TriZol (Invitrogen, Grand Island, NY) using a glass homogenizer, and RNA purification was conducted according to manufacturer's instructions. Aqueous and phenol phases were separated by centrifugation after the addition of 1-bromo-3-chloropropane. RNA was precipitated from the aqueous layer with isopropyl alcohol and washed with 75% ethanol. DNA contaminants were removed by on-column digestion with DNase 1 followed by purification using Qiagen RNeasy minicolumns (Qiagen, Valencia, CA).
Quantitative real-time PCR. Kidney RNA was transcribed to cDNA using an iScript kit (Bio-Rad, Hercules, CA). Gene-specific targets were amplified and analyzed by real-time PCR with a MyIQ cycler (Bio-Rad) and Sybr Green (IQ Supermix; Bio-Rad). To normalize gene expression, the geometric mean of expression of RNA for ␤-actin; ribosomal protein L13a; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide; and succinate dehydrogenase complex, subunit a, flavoprotein was calculated for each sample (91) . Primer sequences are indicated in Table 1 . All expression values were calculated relative to the mean expression in SD ϩ saline.
Statistics. Values were compared by ANOVA using the Bonferroni correction for multiple comparisons, with a conventional computer program (Statistica, StatSoft, Tulsa, OK). Values are expressed as means Ϯ SE, with P Յ 0.05 considered significant.
RESULTS
Serum and urine chemistry. There was no difference in SCa between the GHS and control SD rats in the absence of exogenous 1,25D ( Table 2) . Injection of 1,25D caused a significant increase in SCa in both groups of rats which also did not differ. There were no differences in SP in any group except for the GHS ϩ 1,25D rats, which had a lower SP than the SD ϩ 1,25D group. Serum PTH was numerically lower, but not significantly different, in the GHS compared with SD rats. Administration of 1,25D led to suppression of PTH below the limit of detection in both groups of rats.
In the absence of exogenous 1,25D, UCa in GHS rats was significantly higher (10.5 Ϯ 0.7 mg/day) than that of SD rats (1.7 Ϯ 0.3 mg/day; Fig. 1 ), as we have previously reported (3, 20, 22, 23, 33) . Injection of 1,25D increased UCa in GHS (41.9 Ϯ 0.7 mg/day) and in SD rats (24.4 Ϯ 1.3 mg/day), and with 1,25D, GHS continued to excrete significantly more UCa Forward
Rpl-13a, ribosomal protein L13a; Sdha, succinate dehydrogenase complex, subunit a, flavoprotein; YWHAZ, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide; ROMK, secretory K channel; CaR, calcium-sensing receptor; NKCC2, Na/K/2Cl transporter; TRPV, transient receptor potential vanilloid; NCX1, Na ϩ /Ca 2ϩ exchanger; PMCA, plasma membrane Ca-ATPase.
than SD rats. While administration of 1,25D increased UCa in both groups there was a greater increase in the GHS (⌬UCa ϭ 29.8 Ϯ 1.8 mg/day) than in the SD rats (⌬UCa ϭ 22.4 Ϯ 1.5 mg/day; P ϭ 0.003), indicating that administration of 1,25D results in a greater increase in biological activity, as measured by the increase in UCa, in GHS than in SD rats perhaps due to the increased number of VDR in the GHS rats.
Urine volume (V) was greater in the GHS than in the SD as we have reported previously (20) (Table 2 ). 1,25D increased UV in both SD and GHS rats and with 1,25D UV continued to be significantly greater in the GHS rats. UP increased markedly with 1,25D in both SD and GHS rats ( Table 2) .
Urine supersaturation. In the absence of exogenous 1,25D, SS with respect to CaOx was greater in the GHS rats than in SD (Fig. 2) . 1,25D led to an increase in CaOx SS in both SD and GHS, which were not different. In the absence of exogenous 1,25D, SS with respect to CaP was numerically greater, but not significantly different, in GHS rats compared with SD. Injection of 1,25D led to an increase in CaP SS with SD but not GHS.
Expression of markers of transcellular Ca transport. Transcellular Ca reabsorption occurs in the distal convoluted tubule. In this portion of the nephron, transient receptor potential vanilloid (TRPV)5 controls Ca entry and calbindin D 28K mediates transcellular transport, while cellular Ca is extruded by the Na ϩ /Ca 2ϩ exchanger NCX1 and the plasma membrane Ca-ATPase PMCA (Refs. 37, 43) . In the rat kidney, the apical Ca transporter TRPV6 is expressed at highest level in the medullary thick ascending limb (86) and potentially may also play a role in Ca reabsorption. There was no difference in the RNA expression of any of these markers of epithelial Ca transport between GHS and SD rats without additional 1,25D ( Fig. 3 and Table 3) .
Injection of 1,25D increased expression of TRPV5, TRPV6, and calbindin D 28K in both GHS and SD rats (Fig. 3) . TRPV6, but not TRPV5 or calbindin D 28K , increased with 1,25D to a greater extent in the GHS than in the SD rats. NCX1 increased in GHS rats given 1,25D (Table 3) . Expression of the FGF23 coreceptor klotho, an activator of TRPV5 (30, 67) , was decreased by 1,25D in SD and in GHS ( Table 3) . Expression of markers of paracellular Ca transport. Considerable renal Ca reabsorption occurs in the thick ascending limb of Henle (TALH), via paracellular transport through tight junctions. TALH tight junctions contain claudin 16 and claudin 19 (47) , and their cation permeability is regulated by claudin 14 (38) . RNA expression of claudin 19 did not differ between SD and GHS in the absence of 1,25D (Table 3) . Exogenous 1,25D increased claudin 19 RNA in both SD and GHS rat kidney. Expression of claudins 16 and 14 as well as ROMK, the outward modulating K channel; NKCC2, the Na/K/2Cl transporter; or CaR, the calcium-sensing receptor, did not differ between SD and GHS with or without 1,25D (Table 3) .
DISCUSSION
In this study we postulated that since the GHS rats have normal levels of S1,25D, their elevated tissue levels of VDR in the Ca-transporting organs, the intestine, bone, and kidney (33, 37) , would be relatively undersaturated with 1,25D compared with the control SD rats. In spite of this relative undersaturation, the GHS rats have Ca transport abnormalities that are consistent with increased vitamin D signaling implying that more 1,25D, leading to greater VDR saturation, would have a larger effect on Ca transport in the GHS than in SD rats. We tested the hypothesis that administration of 1,25D would result in a greater biological response, as manifest by a greater increment in hypercalciuria in GHS, compared with SD, rats. We found that in the GHS rats injection of 1,25D increased the hypercalciuria to a far greater extent than in SD rats.
Compared with control SD rats, the GHS rats have increased intestinal Ca absorption (65), increased bone resorption (54) , and decreased renal tubular Ca reabsorption (90) similar to that of many humans with IH (19) and nonhypercalciuric humans given 1,25D (1, 68) . The source of the increased UCa in the GHS rats cannot simply be due to the decreased renal tubule Ca reabsorption found in these animals (90) or SCa would be lower and PTH higher in GHS compared with SD rats, which has not been observed (24) . The augmented UCa must be due either to a greater increase in intestinal Ca absorption and/or bone Ca resorption, the only two potential sources for UCa (15) . Previously, we have shown that when cultured with a similar amount of 1,25D (54) GHS rat bone releases more Ca than bone from SD rats, supporting the current findings. We have also shown that GHS rats absorb more intestinal Ca at a lower level of circulating 1,25D than do SD rats (65) , again supporting our current observations. Since the effect of 1,25D on renal tubule Ca reabsorption is the final determinant of UCa, we chose to study the response to 1,25D for each of the known components of renal tubule Ca transport. As PTH increases renal tubule Ca reabsorption (32) , in this study we gave sufficient 1,25D to suppress PTH to nondetectable levels, eliminating any effect of this hormone on renal tubular Ca reabsorption.
The GHS rats were hypercalciuric compared with SD, and the injection of 1,25D increased the hypercalciuria in the GHS more than in the SD rats, supporting our initial hypothesis. In both the SD and GHS rats, 1,25D increased UP, perhaps due to a 1,25D-induced increase in the phosphaturic hormone FGF23 (81) . SCa increased in both SD ϩ 1,25D and GHS ϩ 1,25D, suggesting that intestinal Ca absorption increased more than urinary Ca excretion. However, SP decreased in GHS ϩ 1,25D, presumably due to a greater increase in UP than any increase in intestinal P absorption.
UV was higher in GHS rats, a consistent finding for this strain (20) , and was increased by 1,25D in both SD and GHS. Hypercalcemia and hypercalciuria induced with oral dihydrotachysterol, a synthetic vitamin D analog, in rats (92) and hypervitaminosis D in humans (50, 53) are associated with polyuria. Activation of the Ca-sensing receptor by the hyper- calciuria may decrease vasopressin-induced water reabsorption (82) in the cortical collecting duct, although this purported mechanism is controversial (9) .
In this study, all rats were fed equivalent amounts of the same formulated diet, yet UOx was increased by 1,25D in both SD and GHS. The increase in intestinal Ca absorption may have led to greater free oxalate in the intestine with subsequent greater absorption and excretion of oxalate (62) . Alterations in the VDR do not appear to affect oxalate transport. In a small clinical study, while patients with a VDR polymorphism had greater CaOx SS, there was no change in UOx excretion (72) .
Administration of 1,25D had significant effects on measured parameters of U acid excretion. U sulfate increased significantly in the GHS and the SD rats when treated with 1,25D. The increase in sulfate observed here with 1,25D must represent greater oxidation of sulfur-containing amino acids (63) , either by absorbing a larger percentage of methionine and/or cysteine delivered in the diet or through increased protein catabolism. However, vitamin D is also known to regulate RNA and protein levels of the anion transporter NaSi-1, important in the regulation of renal tubular sulfate reabsorption (7) . In rats, 1,25D deficiency decreases plasma sulfate while increasing the fractional excretion of sulphate and these effects are normalized with 1,25D (35) . We are not aware of any studies on direct effects of 1,25D on ammonium excretion. The increase in U ammonium and P excretion combined with a reduction in U pH indicates an increase in net acid excretion in the SD and GHS rats treated with 1,25D, supporting the premise that the increased U sulfate represents an acid load to the animals. U citrate excretion is higher with administration of 1,25D in both SD and GHS rats, opposite of the fall one would expect during acid loading. While 1,25D-induced bone resorption would stimulate the release of anionic proton buffers, the finding of increased U citrate is still not consistent with the increase in net acid excretion in the rats treated with 1,25D. Whether 1,25D treatment leads to reduced proximal tubule citrate reabsorption is not known. Okamoto et al. (77) found a trend to higher U citrate in male Wister rats treated with 1,25D. While studies in humans demonstrated a link between VDR polymorphisms and tubular reabsorption of citrate (62, 73), we are not aware of any studies directly linking 1,25D levels and citrate excretion. The mechanisms by which 1,25D alters U citrate, sulfate, and acid production remain to be determined.
Without 1,25D, SS for CaOx was higher in the GHS than the SD rats because UCa is much higher in the GHS rats and UOx is similar between the strains. With 1,25D, the SS CaOx increases significantly in both strains so that the GHS and SD rats have equivalent levels of SS CaOx, despite higher UCa in GHS rats. The UV is higher in GHS compared with SD, which offsets the higher UCa to some extent. However, the main reason for the equivalent SS CaOx between the strains is the extreme excess of UCa to Ox. The mean molar ratio of Ca to Ox is 54 to 1 in the SD rats; in the GHS rats it reaches 81 to 1. There is such an excess of Ca to Ox that there is insufficient Ox available to drive SS despite the ever increasing Ca (89). Without 1,25D the SS for CaP was higher in GHS compared with SD rats, as the far higher UCa more than offset the effects of a more acidic U and higher UV in the GHS rats. When treated with 1,25D, the SS for CaP was lower in the GHS than the SD rats. With 1,25D there was only a 1.7-fold increase in UCa in the GHS, so the effects of the more acidic U and higher UV in the GHS rats led to a significantly lower SS CaP.
In mammals, SCa levels are tightly regulated (26) , in part by the extent of renal tubular Ca reabsorption. Renal tubular Ca reabsorption occurs via paracellular and transepithelial transport (37, 43) . Paracellular transport primarily occurs in the proximal tubule and TALH (64) . In the TALH Ca passes through intercellular tight junctions largely composed of claudins 16 (paracellin) and 19 (40, 47) . Permeability is repressed by claudin 14 interaction with claudin 16, and expression of claudin 14 is regulated by the CaR (38) . Ca reabsorption results from a positive lumen potential generated by a K gradient produced from the combined activity of the Na/K/2Cl transporter NKCC2 and the secretory K channel ROMK. The activity of ROMK, and thus K concentration, can be modulated by Ca through CaR (85) . Further reabsorption occurs distally; this transepithelial reabsorption is active and regulated by 1,25D and PTH (43, 69) . Ca enters the cell through TRPV5 and is shuttled to the basolateral surface by calbindin D28k (41, 69) . Ca is extruded from the cell by the Na/Ca exchanger NCX1 and the plasma membrane Ca ATPase PMCA. While expression of TRPV5 is limited to kidney (41) and mouse testis (49), a second apical Ca transporter, TRPV6, is found in multiple tissues (49, 93) with highest kidney expression in TALH (75) . While the apical distribution of renal TRPV6 and its known role in intestinal Ca absorption (66, 95) is consistent with renal tubular Ca reabsorption, direct evidence is lacking.
In this study while baseline expressions of TRPV5 and calbindin D 28k were not different, both were increased to a similar extent by 1,25D in both SD and GHS. Retention of TRPV5 in the plasma membrane requires cleavage of its terminal sialic acid residue by klotho (30, 67) . Klotho expression was suppressed similarly by 1,25D in both SD and GHS. In contrast, in chronic kidney disease (CKD) mice fed a high-P (36) . The reasons for these differences are not clear; however, steady-state klotho RNA levels in kidneys from renal-competent animals may well differ from CKD animals. A modest decrease in klotho could lead to marked inhibition of Ca reabsorption. The phenotype of klotho Ϫ/Ϫ mice includes hypercalciuria, although unlike GHS, these mice are also hypercalcemic and show CaP precipitation in soft tissues (2). NCX1 was not elevated by 1,25D in SD but increased in GHS.
The elevation of TRPV6 by 1,25D was the most striking alteration in renal Ca transport pathways in GHS rats. Other studies have found renal expression of TRPV6 increases with many (58 -60), but not all (79), models of hypercalciuria. An haplotype of TRPV6, whose expression in vitro increases Ca transport, was associated with increased risk of kidney stones (87) . Ablation of either TRPV5 (42) or TRPV6 (11) in mice leads to hypercalciuria, suggesting that the transporters are not redundant. However, hypercalciuria in TRPV6 Ϫ/Ϫ mice may be a result of secondary hyperparathyroidism (11) and not a primary defect in renal Ca reabsorption. While neither TRPV6 nor calbindin D 9K are required for 1,25D-stimulated intestinal Ca transport in mice (8, 55) on a Ca-restricted diet, TRPV6 Ϫ/Ϫ mice exhibit greater bone resorption (66) , suggesting that TRPV6 is important to maintain normal Ca balance. Knockin of a mutated TRPV6 incapable of Ca permeation led to impaired intestinal Ca uptake with a limited Ca diet (95) . The increases observed in RNA encoding these active Ca transporters, TRPV5 and TRPV6, with 1,25D should lead to additional renal tubular Ca reabsorption and a reduction in hypercalciuria, especially in the GHS rats given 1,25D in which TRPV6 increased more than in SD. However, protein abundance and transporter activity have not yet been studied in these rats.
Alterations in paracellular renal Ca transport can alter Ca homeostasis. In humans, mutations in claudin 16 or 19 cause familial hypomagnesemia, hypercalciuria, and nephrocalcinosis (13) . A genome-wide association study in patients with kidney stones identified sequence variants, which were associated with hypercalciuria, in a third claudin gene, CLDN14 (88) , which regulates tight junction cation permeability (38) . In the data presented here, expression of claudin 19 did not differ between SD and GHS in the absence of 1,25D while 1,25D increased claudin 19 RNA in both SD and GHS rats. There was no change in expression of any other components of paracellular transport (claudin 16, claudin 14, ROMK, NKCC2, and CaR) observed in either SD or GHS with or without 1,25D. We previously reported increased levels of CaR mRNA and protein in the GHS rat kidneys at baseline and after acute stimulation with 1,25D (97) . Possibly the increase in mRNA is transient and normalized by the end of this study, while higher CaR protein levels may persist. Increased CaR levels should tend to heighten sensitivity to S and UCa.
In spite of the increased expression of TRPV6 and NCX1 with 1,25D, which should increase renal tubular Ca reabsorption if reflected in increased protein expression and activity, we found that 1,25D increased UCa excretion significantly more in the GHS than in the SD rats. This indicates that the 1,25D-mediated increase in intestinal Ca absorption and/or bone Ca resorption overwhelmed any increase in renal tubular Ca reabsorption. Future studies will be necessary to determine if there are any differences in intestinal Ca transporters or bone resorption markers in the GHS compared with SD rats to further understand the alterations that ultimately lead to the 1,25D induced increased hypercalciuria in the GHS rat.
Thus in this study we postulated that since the GHS rats have normal levels of S1,25D, their elevated tissue levels of VDR in the Ca-transporting organs would be relatively undersaturated with 1,25D compared with SD rats. We tested the hypothesis that additional 1,25D, which should result in greater VDR saturation, would lead to greater UCa excretion in the GHS than in SD rats. We found that administration of 1,25D to the GHS rats increased the hypercalciuria to a greater extent than in SD. This additional UCa, which must come from either increased intestinal Ca absorption and/or enhanced bone Ca resorption, must exceed any 1,25D-induced increase in renal tubule Ca reabsorption, resulting in increased hypercalciuria. The 1,25D-induced increases in the mRNA for the renal Ca-transporting proteins, including TRPV6 and NCX1, is not sufficient to limit the hypercalciuria in the GHS rats.
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